Literature DB >> 8783710

Pneumococcal pleural empyemas in children.

W Hardie1, R Bokulic, V F Garcia, S F Reising, C D Christie.   

Abstract

Empyema rarely complicates pneumonia. In a 361-bed regional pediatric hospital, 50 pleural empyemas were identified from 1988 through 1994; 17 (34%) occurred in the last 12 months of this period, for which the incidence was 3.3 per 100,000 of the population aged < or = 18 years (P < .05, chi 2 test). A significant seasonal prevalence was observed: 50% of cases occurred in the winter (P < .001, chi 2 test). In contrast with the findings of previous studies, in which empyemas predominantly occurred in infants, the median age of our patients was 7 years; underlying illnesses were present in only 10%, and all had community-acquired disease. Eighty-two percent had chest tubes inserted, 56% required a thoracotomy with pleural decortication, and 2% had a lobectomy. There were no deaths. Streptococcus pneumoniae was isolated in 40% of the cases; specimens in 44% of the cases were sterile. None of the empyemas were associated with Staphylococcus aureus or Haemophilus influenzae type b, and only one was caused by group A streptococcus. Among 13 S. pneumoniae isolates, the rate of resistance to penicillin was 15%; to erythromycin, 15%; to chloramphenicol, 31%; and to cefotaxime, 23%. The penicillin-resistance rate among blood and cerebrospinal fluid pneumococcal isolates was 17% during 1993-1994. Drug-resistant S. pneumoniae is now a recognized cause of pleural empyemas in children.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8783710     DOI: 10.1093/clinids/22.6.1057

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  20 in total

1.  BTS guidelines for the management of pleural infection in children.

Authors:  I M Balfour-Lynn; E Abrahamson; G Cohen; J Hartley; S King; D Parikh; D Spencer; A H Thomson; D Urquhart
Journal:  Thorax       Date:  2005-02       Impact factor: 9.139

2.  Empyema: the use of broad range 16S rDNA PCR for pathogen detection.

Authors:  S Saglani; K A Harris; C Wallis; J C Hartley
Journal:  Arch Dis Child       Date:  2005-01       Impact factor: 3.791

3.  Outcome of parapneumonic empyema.

Authors:  S K Satpathy; C K Behera; P Nanda
Journal:  Indian J Pediatr       Date:  2005-03       Impact factor: 1.967

4.  Establishing Equipoise: National Survey of the Treatment of Pediatric Para-Pneumonic Effusion and Empyema.

Authors:  Morgan K Richards; Jarod P Mcateer; Todd C Edwards; Lucas R Hoffman; Matthew P Kronman; Dennis W Shaw; Adam B Goldin
Journal:  Surg Infect (Larchmt)       Date:  2016-11-29       Impact factor: 2.150

5.  Postpneumonic empyema in childhood.

Authors:  N Belet; S Uysal; E Bernay; N Gurses
Journal:  Indian J Pediatr       Date:  2001-01       Impact factor: 1.967

Review 6.  Clinical practice: treatment of childhood empyema.

Authors:  Marijke Proesmans; Kris De Boeck
Journal:  Eur J Pediatr       Date:  2009-02-24       Impact factor: 3.183

7.  Bacterial induction of early response genes and activation of proapoptotic factors in pleural mesothelial cells.

Authors:  Kamal A Mohammed; Najmunnisa Nasreen; Veena B Antony
Journal:  Lung       Date:  2007-10-10       Impact factor: 2.584

8.  Pneumococcal necrotizing pneumonia in Utah: does serotype matter?

Authors:  Jeffrey M Bender; Krow Ampofo; Kent Korgenski; Judy Daly; Andrew T Pavia; Edward O Mason; Carrie L Byington
Journal:  Clin Infect Dis       Date:  2008-05-01       Impact factor: 9.079

9.  Clonality of Streptococcus pneumoniae serotype 1 isolates from pediatric patients in the United States.

Authors:  Blanca E Gonzalez; Kristina G Hulten; Sheldon L Kaplan; Edward O Mason
Journal:  J Clin Microbiol       Date:  2004-06       Impact factor: 5.948

10.  Thoracic empyema with scarlatiniform rash and acral desquamation: a case report.

Authors:  John Scott Baird; Ivona Sediva
Journal:  Cases J       Date:  2009-12-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.